Showing results (11-20 of 109) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancerM L Disis, S M Pupa, J R Gralow, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-proteinM L Disis, J R Gralow, H Bernhard, et al.Ciba Foundation Symposium|January 1, 1994
Immunity to the HER-2/neu oncogenic proteinM L Disis, H Bernhard, J R Gralow, et al.Human Immunology|February 1, 1997
Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8J Lustgarten, M Theobald, C Labadie, et al.Blood|July 1, 1996
Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccinesM L Disis, H Bernhard, F M Shiota, et al.Seminars in Oncology|January 5, 2002
Cancer vaccines targeting the HER2/neu oncogenic proteinM L Disis, K SchiffmanCancer Research|July 15, 1995
CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patientsH Qin, W Chen, M Takahashi, et al.Clinical Breast Cancer|March 20, 2002
Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccineK L Knutson, M L DisisArchivum Immunologiae Et Therapiae Experimentalis|May 12, 2000
Tumor vaccines for the management of prostate cancerD G McNeel, M L DisisClinical and Experimental Immunology|January 24, 2004
IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansionK L Knutson, M L DisisPageof 11